Clinical Trials and Research Studies
At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.
Recently Added/Updated Trials
-
Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes
In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ... -
A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...
-
EVALUATION OF FREQUENCY ALLOCATION TABLES FOR RECENTLY IMPLANTED SINGLE-SIDED DEAF COCHLEAR IMPLANT USERS
This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ... -
The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents
The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment ... -
Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination with VS-6766 and Defactinib in Patients with Previously Untreated Metastatic Adenocarcinoma of the Pancreas
This study is about testing a combination of drugs (gemcitabine, nab-paclitaxel, VS-6766, and defactinib) to treat a type of cancer called pancreatic ductal adenocarcinoma (PDAC ...
-
Phase 1 First-In-Human Study to Explore the Safety Tolerability and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
This study is investigating a drug called AMG 305, which is designed to target specific cancer cells that have CDH3 and MSLN. This is a ...
-
A multicenter international randomized placebo controlled double-blind parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years or older.
OCEANIC-STROKE (study 20604) is a multicenter, international, randomized, placebo controlled, double-blind, parallel group, event driven phase 3 study. The purpose of this study is to ... -
Predicting adenomatous polyps using images of a human tongue
This study evaluates the performance of Gixam in predicting the presence of adenomatous polyps using an image of a human tongue. The Gixam system is ...
Volunteer Sign-up
Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.
